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Objectives: The natural history of stage 1 Twin-to-twin transfusion syndrome (TTTS) remains unclear and
its optimal management is yet to be established. The main aims of this meta-analysis were to quantify the
incidence of progression in stage 1 TTTS and to ascertain survival in these pregnancies.
Methods: MEDLINE, EMBASE, and The Cochrane Library were searched. Reference lists within each article
were hand-searched for additional reports. The outcomes included incidence of progression and survival in
stage 1 TTTS. Randomized controlled trials, cohort and case-control studies were included. Case reports,
studies including three or fewer cases of stage 1 TTTS, and editorials were excluded. Proportion meta-
analysis was used for analysis (Registration number: CRD42016036190).
Results: The search yielded 3,085 citations; 18 studies were included in the review (172 pregnancies to
assess progression and 433 pregnancies to assess the survival). The pooled incidence of progression in
stage 1 TTTS was 27% [95% CI 16–39%]. The pooled overall survival, double survival and at least one survival
in the pregnancies managed expectantly were 79% [95% CI 62–92%], 70% [95% CI 54–84%] and 87% [95%
CI 69–98%], respectively. In those undergoing amnioreduction, the corresponding figures were 77% [95%
CI 68–85%], 67% [95% CI 57–76%] and 86% [95% CI 76–94%], respectively. The survival rates were 68%
[95% CI 54–81%], 54% [95% CI 36–72%], and 81% [95% CI 69–90%], when laser surgery was performed.
Conclusions: The optimal initial management of stage 1 TTTS remains in equipoise. The ongoing random-
ized trial comparing immediate laser surgery versus conservative management should provide a definitive
answer.
 Keywords: twin-to-twin transfusion syndrome, TTTS, stage 1, progression, survival, laser, amniodrainage,
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TTTS affects 10–15% of monochorionic twin pregnancies
and is associated with increased perinatal mortality and
morbidity (Berghella & Kaufmann, 2001). If untreated, it
leads to fetal demise in up to 90% of cases, with morbidity
rates in survivors of over 50% (Roberts et al., 2008; 2014).
Early diagnosis, however, may allow intervention with fe-
toscopic laser ablation, which significantly improves the
prognosis. Laser treatment in these pregnancies results in
60–70% double survival and 80–90% of women being able
to take home at least one baby (Baschat et al., 2013; Roberts
et al., 2014).
While the exchange of blood between the twins through
placental vascular anastomoses is quite common in these
pregnancies, it is the imbalance in the degree of transfusion
that leads to the development of TTTS. TTTS is currently
classified using the Quintero staging system (Quintero et al.,
1999; 2003). It has been questioned whether stage I TTTS
truly represents the first in a chronological series of stages of
deterioration, and suggested that it might not predict sur-
vival well after treatment. While incorporation of additional
cardiovascular parameters stratifies additional disease fea-
tures independent of the Quintero staging, these do not
improve prediction of outcome following treatment. Nev-
ertheless, the Quintero staging system remains the most
commonly used for the classification of twin pregnancies
complicated by TTTS.
Despite the fact that the Eurofetus trial has demon-
strated clear superiority of fetoscopic laser ablation over
amnioreduction in the treatment of severe TTTS, only 11
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pregnancies were stage 1 TTTS, hindering any meaningful
statistical subanalyses (Senat et al., 2004). Furthermore,
the natural history of stage 1 TTTS is unclear. Studies have
reported controversial rates of progression in stage 1 TTTS,
from as low as 10% (Bebbington et al., 2010) to as high as
45–50% (Dickinson & Evans, 2004; Duryea et al., 2016).
For these reasons, the optimal treatment of stage 1 TTTS is
yet to be established. Many centers manage Quintero stage
I conservatively. Older studies have advocated the use of
amnioreduction as an acceptable treatment in these cases
(Bebbington et al., 2010; Dickinson & Evans, 2004; Taylor
et al., 2000), and more recent studies have used laser, either
in progressive cases or as a first-line treatment (Chmait et al.,
2011; Huber et al., 2006; Quintero et al., 2003; Wagner et al.,
2009).
In a systematic review of the management of stage 1
TTTS, the overall survival appeared to be similar for laser
therapy and conservative management (85% and 86% re-
spectively), but somewhat lower for amnioreduction (77%;
Rossi & D’Addario, 2013). Of note, this review included
seven articles, searched the literature between 1999 and
2011, and assessed the progression even in those pregnan-
cies undergoing intervention, that is, amnioreduction or
laser, and did not perform meta-analysis or assessment of
the quality of the included studies (Rossi & D’Addario,
2013). The main aims of this meta-analysis were to quan-
tify the incidence of progression in stage 1 TTTS and to
ascertain survival in these pregnancies.
Methods
Protocol, Eligibility Criteria, Information Sources, and
Search
This review was performed according to a protocol de-
signed a priori and recommended for systematic reviews
and meta-analysis (Henderson et al., 2010; NHS Cen-
tre, 2009; Stroup et al., 2000). MEDLINE (1946–January
2016), EMBASE (1947–January 2016) and The Cochrane
Library (since inception) including The Cochrane Database
of Systematic Reviews (CDSR), Database of Abstracts of
Reviews of Effects (DARE) and The Cochrane Central
Register of Controlled Trials (CENTRAL) were searched
electronically on January 27, 2016, utilizing combina-
tions of the relevant MeSH terms, key words, and word
variants for ‘TTTS’, ‘progression’, ‘stage’, ‘survival’, ‘fetal
loss’ (Supplementary Table 1). The search was restricted
to the English language. Reference lists of relevant arti-
cles and reviews were hand searched for additional re-
ports. The MOOSE guidelines were followed (Stroup,
2000). The study was registered with the PROSPERO
database (Registration number: CRD CRD42016036190,
http://www.crd.york.ac.uk/PROSPERO).
Study Selection, Data Collection, and Data Items
Studies were assessed according to the following criteria:
population, outcome, study design, and prenatal interven-
tion. Studies reporting the incidence of progression or the
survival rate in twin pregnancies complicated by Quintero
stage 1 TTTS were included. The diagnosis of TTTS relied
on the standard criteria of oligohydramnios in the donor’s
sac (maximal vertical pocket 2 cm) and polyhydramnios
in the recipient’s sac (maximal vertical pocket8 cm). The
Quintero staging system was proposed to assess the severity
of TTTS using the following criteria: stage I: visualization
of donor’s bladder; stage II: bladder not visualized in the
donor twin; stage III: abnormal Doppler of the umbilical
artery and/or ductus venosus in one or both twins; stage IV:
hydrops in one or both twins; stage V: intrauterine demise
of one or both twins (Quintero et al., 1999). Cases were
excluded if they were treated with selective feticide or the
survival rates were not stratified by TTTS stages.
All abstracts were reviewed independently by two au-
thors. Agreement about potential relevance was reached by
consensus, and full text copies of those papers were ob-
tained. The same two reviewers independently extracted
data regarding study characteristics and outcomes. Incon-
sistencies were discussed by the reviewers and consensus
reached. For those articles in which information was not
reported but the methodology was such that this informa-
tion would have been recorded initially, the authors were
contacted. If more than one study was published for the
same cohort with identical endpoints, the report contain-
ing the most comprehensive information on the population
was included to avoid overlapping populations.
The outcomes observed in this systematic review were
the incidence of progression and the survival. Progression
was defined as an increase in stage (from stage 1 to stage
2 or higher) or progressing polyhydramnios with a short-
ening cervix, and was assessed in the pregnancies that were
managed expectantly. The survival included the overall sur-
vival, double survival (both twins survived) and at least
one survival (at least one twin survived). Randomized con-
trolled trials, prospective and retrospective cohort, case-
control studies and case series with more than three twin
pregnancies complicated by Quintero stage 1 TTTS were
included. Case reports, conference abstracts, and editorials
were excluded.
Risk of Bias, Summary Measures, and Synthesis of the
Results
Quality of the included studies was assessed using the
Strengthening the Reporting of Observational Studies in
Epidemiology statement criteria (Stroup, 2000). We used
random-effect meta-analyses of proportions to combine
data (Hunter et al., 2014; Manzoli et al., 2011). The sur-
vival was analyzed according to the intervention received,
including conservative management, amnioreduction,
and endoscopic laser photocoagulation. Between-study
heterogeneity was assessed using the I2 statistic (Higgins
et al., 2003). Publication bias was explored using funnel
plots and was assessed statistically using the Egger test
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FIGURE 1
Flow of study identification.
Note: TTTS = Twin-to-twin transfusion syndrome.
(which uses the actual values of the effect sizes and their
precision, rather than ranks; Sterne & Egger, 2001). The
assessment of the potential publication bias was problem-
atic because of the low number of individual studies, which
strongly limits the reliability of formal tests. Funnel plots
displaying the outcome rate from individual studies versus
their precision (1/standard error) were carried out with an
exploratory aim. Tests for funnel plot asymmetry were not
used when the total number of publications included for
each outcome was less than 10. In this case, the power of the
tests is too low to distinguish chance from real asymmetry
(Higgins & Green, 2009).
Statistical analyses were performed using Stats Direct
(Version 2.7.8, Stats Direct Ltd, 9 Bonville Chase, Altrin-
cham, Cheshire WA14 4QA, UK) statistical software.
Results
The search yielded 3,085 citations; of these, 3,052 were ex-
cluded by review of the title or abstract, as they did not meet
the selection criteria, contain original data, were not rele-
vant, contained data on three cases or less, or had data which
were included in another study (Figure 1). Full manuscripts
were retrieved for the remaining 33, and a total of 18 stud-
ies were included in the review. Seven studies reported data
on progression (172 pregnancies with stage 1 TTTS), while
data on survival were reported in 16 studies (433 preg-
nancies with stage 1 TTTS; Figure 1). Table 1 shows the
characteristics of the studies included in this systematic
review.
Progression in Twin Pregnancies Complicated by Quin-
tero Stage 1 TTTS
Seven studies reported the incidence of progression in stage
1 TTTS managed expectantly (Bebbington et al., 2010;
Dickinson & Evans, 2004; Duryea et al., 2016; Meriki et al.,
2010; O’Donoghue et al., 2007; Taylor et al., 2002; Wagner
et al., 2009). The pooled incidence of progression in these
pregnancies was 27% [95% CI 16–39%] (Figure 2). The re-
ported rate of progression in the included studies varied
from as low as 10% to as high as 50%. The number of preg-
nancies with stage 1 TTTS reported in these studies ranged
between 9 and 46.
Survival in Twin Pregnancies Complicated by Quintero
Stage 1 TTTS Managed Expectantly
Four studies (73 pregnancies) reported the survival rates
in pregnancies with stage 1 TTTS that were managed ex-
pectantly (Bebbington et al., 2010; Luks et al., 2009; Meriki
et al., 2010; Wagner et al., 2009). The pooled overall sur-
vival, double survival, and at least one survival were 79%
[95% CI 62–92%], 70% [95% CI 54–84%] and 87% [95%
CI 69–98%], respectively (Figure 3).The highest survival
rate was reported in the study by Meriki et al. (2010), which
had only 9 pregnancies, while the lowest survival rate was
reported in the study by Luks et al. (2009) which had 14
pregnancies.
Survival in Twin Pregnancies Complicated by Quintero
Stage 1 TTTS Managed by Amnioreduction
Eight studies (147 pregnancies) reported the survival rates
in pregnancies with stage 1 TTTS that were managed by
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TABLE 1
Summary of the 18 Studies Included Which Reported Progression or Survival in Twin Pregnancies Complicated by Quintero Stage 1
Twin-To-Twin Transfusion Syndrome (TTTS)
Author, year Country
Study
design
Data
collection
Pregnancies
with stage 1
TTTS (n)
Inclusion
criteria Intervention
Quintero et al.,
1999
USA Cohort Prospective 6 TTTS Expectant (stage I), serial amnioreduction
(stage I), laser
Taylor et al.,
2002
USA Cohort Prospective 13 TTTS Serial amnioreduction, septostomy, selective
reduction
Blaicher et al.,
2002
Austria Cohort Prospective 13 TTTS Amnioreduction
Quintero et al.,
2003
USA/Australia Cohort Prospective 32 TTTS Serial amnioreduction, laser
Tan et al., 2004 UK Cohort Prospective 35 TTTS Serial amnioreduction, septostomy, or bipolar
cord occlusion when one twin is preterminal
Dickinson et al.,
2004
Australia Cohort Prospective 22 TTTS Amnioreduction
Huber et al.,
2006
Germany Cohort Prospective 29 TTTS Fetoscopic laser ablation
O’Donoghue
et al., 2007
UK Cohort Retrospective 46 TTTS stage I Conservative, amnioreduction
Luks et al.,
2009
USA cohort Prospective 14 TTTS Expectant or laser
Wagner et al.,
2009
Netherlands Cohort Retrospective 50 TTTS stage I Conservative, laser
Bebbington
et al., 2010
USA Cohort Retrospective 42 TTTS stage I Conservative, amnioreduction, laser if
progressed
Fichera et al.,
2010
Italy Cohort Retrospective 19 TTTS Amnioreduction
Meriki et al.,
2010
Australia Cohort Retrospective 9 TTTS
undergoing
laser therapy
Laser
Chmait et al.,
2011
USA Cohort Prospective 114 TTTS
undergoing
laser therapy
Laser
Sundberg
et al., 2012
Denmark Cohort Retrospective 12 TTTS Laser or cord occlusion
Has et al., 2014 Turkey Cohort Retrospective 12 TTTS Fetoscopic laser ablation
Mu¨ller et al.,
2015
Ireland Audit Retrospective 9 TTTS
undergoing
laser therapy
Fetoscopic laser ablation
Duryea et al.,
2016
USA Cohort Retrospective 18 TTTS Conservative, amnioreduction, or laser ablation
amnioreduction (Bebbington et al., 2010; Blaicher et al.,
2002; Dickinson & Evans, 2004; Fichera et al., 2010; Quin-
tero et al., 1999; Tan et al., 2004; Taylor et al., 2002). The
pooled overall survival, double survival, and at least one sur-
vival were 77% [95% CI 68–85%], 67% [95% CI 57–76%]
and 86% [95% CI 76–94%], respectively (Figure 4).The
highest survival rate was reported in the studies by Blaicher
et al. (2002) and Quintero et al. (2003), which had 13 and
11 pregnancies, respectively. The lowest survival rates were
reported by the older study by Quintero et al. (1999) and
Taylor et al. (2002), which had 10 and 13 pregnancies, re-
spectively.
Survival in Twin Pregnancies Complicated by Quintero
Stage 1 TTTS Managed by Endoscopic Laser Photoco-
agulation
Four studies (51 pregnancies) reported the survival rates
in pregnancies with stage 1 TTTS that were managed by
laser (Has et al., 2014; Mu¨llers et al., 2015; Sundberg et al.,
2012; Wagner et al., 2009). The pooled overall survival,
double survival, and at least one survival were 68% [95%
CI 54–81%], 54% [95% CI 36–72%) and 81% [95% CI 69–
90%], respectively (Figure 5). The lowest survival rate was
reported by the study by Has et al. (2014), which included
12 pregnancies with stage 1 TTTS. The largest study, by
Wagner et al. (2009), included 20 pregnancies and reported
a double survival rate of 65%.
Survival in Twin Pregnancies Complicated By Quintero
Stage 1 TTTS Managed By Endoscopic Laser Photoco-
agulation as the First-Line Treatment
Three studies (162 pregnancies) reported the survival rates
in pregnancies with stage 1 TTTS that were managed by laser
as the first-line treatment (Chmait et al., 2011; Huber et al.,
2006; Quintero et al., 2003). The pooled overall survival,
double survival, and at least one survival were 84% [95%
CI 79–88%], 77% [95% CI 71–83%] and 91% [95% CI 86–
95%], respectively (Figure 6). The lowest survival rate was
reported by the oldest of the four studies (Quintero et al.,
2003), which included the smallest number of pregnancies
(21 pregnancies with stage 1 TTTS) and reported a double
survival rate of 67%. The largest study, by Chmait et al.
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FIGURE 2
(Colour online) Pooled incidence (forest plot) of progression in
twin pregnancies complicated by Quintero stage 1 twin-to-twin
transfusion syndrome (TTTS). Each study is represented by a line.
The box in the middle of the line represents the point effect esti-
mate of this particular study. The midpoint of the box represents
the point effect estimate, that is, the mean effect estimate for
each study. The area of the box represents the weight given to
the study. The diamond below the studies represents the over-
all estimate. The width of the line shows the confidence interval
(CI) of the effect estimate of individual studies. The width of the
diamond shows the CI for the overall effect estimate.
Note: N = total number in group, while n = number in group with
the outcome. Heterogeneity (I2) = diversity between studies.
(2011), included 112 pregnancies with stage 1 TTTS and
reported a double survival rate of 80%.
Quality Assessment of the Included Studies
The quality of the studies is summarized in Figure 7. Among
the studies included in this review, the title, abstract, study
design, eligibility, data variables, data sources, assessment
methods, explanation of the quantitative variables, and their
analysis, summary of the key findings and the interpreta-
tion of the studies were appropriately described in 100%.
On the other hand, explanation of study size (sample size
calculation) was reported in none, and flow diagrams to de-
scribe the study population were rarely used. However, the
background, objectives, study setting, recruitment period,
and reporting number of outcome events were described
in more than 90% of these studies. The statistical methods
were adequately described in more than 80% of the studies.
Efforts to address bias and acknowledging the limitations
of the study were reported in approximately 50% of the
studies (Figure 7).
Discussion
Summary of Findings
The findings of this meta-analysis suggest that the incidence
of progression in stage 1 TTTS was 27%. The pooled overall
survival was 79%, 77%, 68%, and 84% in stage 1 TTTS man-
aged expectantly, by amnioreduction, laser if there is pro-
gression, and laser as first-line treatment, respectively. The
FIGURE 3
(Colour online) Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome
(TTTS) managed conservatively. The overall survival (a), double survival, (b) and at least one survival (c) are shown. Each study is
represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the
box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight
given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval
(CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Note: N = total number in group, while n = number in group with the outcome. Heterogeneity (I2) = diversity between studies.
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FIGURE 4
(Colour online) Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome
(TTTS) managed by amnioreduction. The overall survival (a), double survival (b), and at least 1 survival (c) are shown. Each study is
represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the
box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight
given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval
(CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Note: N = total number in group, while n = number in group with the outcome. Heterogeneity (I2) = diversity between studies.
corresponding pooled double survival figures were 70%,
67%, 54%, and 77%, respectively. Lastly, the corresponding
pooled at least one survival figures were 87%, 86%, 81%,
and 91%, respectively.
Interpretation of the Findings
Stage 1 TTTS progresses to a higher stage or more severe
polyhydramnios in approximately one quarter of the preg-
nancies. There is a considerable variation in the incidence
of progression reported in the published studies. One po-
tential explanation could be the variation of the criteria
for defining progression across the studies. Most of the in-
cluded studies defined progression as an increase in stage
(from stage 1 to stage 2 or higher), so potentially have un-
derestimated the risk of progression.
The survival rates in the various subgroups, according
to the management of stage 1 TTTS, do not show marked
variation, but suggest that laser surgery as a first-line treat-
ment might be associated with better survival. However,
these results should be interpreted with caution as they are
derived from observational data with their inherent risk of
bias. The survival rates associated with amnioreduction or
laser as the management of cases that had progressed, are
likely to be worse than those which did not progress, so were
managed expectantly, or in those pregnancies where laser
surgery was performed, as a first-line treatment.
It is generally accepted that TTTS diagnosed before 26
weeks of gestation is best treated by laser ablation as the
evidence suggests that it leads to better outcomes compared
with amnioreduction or septostomy (Roberts et al., 2014).
However, where laser ablation expertise is not available,
an acceptable alternative in pregnancies diagnosed after 26
weeks of gestation is amnioreduction (Roberts et al., 2014).
But there is some evidence that laser ablation is still the
best form of treatment for TTTS, even if diagnosed early
(before 16 weeks) or late (after 26 weeks’ gestation; Baud
et al., 2013; Middeldorp et al., 2007).
Clinical and Research Implications of the Review Find-
ings
In view of the risk of progression in approximately one
quarter of stage 1 TTTS, these pregnancies require regular
weekly monitoring looking for signs of deterioration. This
monitoring should include ultrasound assessment of the
fetal bladders, Dopplers, severity of polyhydramnios, and
cervical length. There is no evidence to date supporting the
use any ultrasound or biochemical markers to predict the
risk of progression in these pregnancies. Furthermore, in
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FIGURE 5
(Colour online) Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome
(TTTS) managed by endoscopic laser photocoagulation. The overall survival (a), double survival (b), and at least 1 survival (c) are shown.
Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study.
The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box
represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows
the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect
estimate.
Note: N = total number in group, while n = number in group with the outcome. Heterogeneity (I2) = diversity between studies.
view of the limited predictive ability of the Quintero staging
system, management decisions should take into account
other known risk factors associated with worse outcome,
such as the gestational age at diagnosis and cervical length.
The results of this meta-analysis present evidence that
the optimal initial management of stage 1 TTTS remains in
equipoise. On one hand, some could argue that three quar-
ters of these cases regress or remain stable, with a survival
rate that is far better than that quoted for the untreated
cases of severe TTTS (80% overall survival in the group
with expectant management vs. 80–90% mortality). On the
other hand, it is true that this survival rate might be over-
optimistic, as it does not take into account those pregnancies
that have progressed and required intervention, or ended
in fetal demise, preterm birth and/or neurological impair-
ment. In fact, postponing surgery could arguably increase
the rates of spontaneous fetal demise and secondary neu-
rological morbidity, as well as preterm premature rupture
of the membranes and very preterm birth. The ongoing
international randomized trial comparing the two man-
agement strategies, immediate percutaneous laser surgery
versus conservative management, in stage 1 TTTS should
provide a definitive answer to this question.
Strengths and Limitations of the Meta-Analysis
The strengths of this meta-analysis are the a priori designed
protocol following the recommended guidelines for sys-
tematic reviews and meta-analysis of observational studies,
the thorough literature search, the assessment of the qual-
ity of the included studies, the quantitative synthesis of
evidence, and the relatively large number of included arti-
cles and pregnancies with stage 1 TTTS, which occurs in a
minority of TTTS cases. The quality of the data available
for meta-analysis limits the current study findings. Small
retrospective observational studies and selection bias were
the main drawbacks. This meta-analysis reported on the
survival, rather than intact survival, in stage 1 TTTS. This
reflects the limited reported data on intact survival in these
pregnancies. When reported, expectant management seems
to be associated with worse short- and long-term neurode-
velopmental outcomes than those pregnancies treated with
laser (Wagner et al., 2009). Moreover, the survival rates in
these pregnancies are influenced by a number of risk factors,
such as the gestational age at diagnosis as well as at treat-
ment, birthweight discordance, type of inter-twin vascular
anastomoses, and placental territory. Unfortunately, these
variables are not reported in the majority of the published
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FIGURE 6
(Colour online) Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome
(TTTS) managed by endoscopic laser photocoagulation as first line. The overall survival (a), double survival (b), and at least 1 survival (c)
are shown. Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular
study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the
box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line
shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall
effect estimate.
Note: N = total number in group, while n = number in group with the outcome. Heterogeneity (I2) = diversity between studies.
FIGURE 7
Quality criteria of the included articles, as assessed using the Strengthening the Reporting of Observational Studies in Epidemiology
checklist.
studies, and furthermore, such analysis would require in-
dividual participant data (IPD) instead of aggregate data
meta-analysis, in order to adjust for these potential con-
founders.
Large, multicenter randomized controlled trials are re-
quired to improve the robustness of the results, and
target intact survival that takes into account the neu-
rodevelopmental outcome of the infants. Prospective na-
tional collection of data on twin pregnancies with stage
1 TTTS, their management and outcomes would be
a valuable source while waiting for the results of the
RCT.
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Conclusion
Progression occurred in 27% of pregnancies with stage 1
TTTS. The overall survival was 79%, 77%, 68%, and 84%
in stage 1 TTTS managed expectantly, by amnioreduction,
laser surgery if there is progression, and laser as first-line
treatment, respectively. The optimal initial management
of stage 1 TTTS remains in equipoise. The ongoing ran-
domized trial comparing immediate laser surgery versus
conservative management in stage 1 TTTS should provide
a definitive answer to this question. Meanwhile, prospec-
tive national collection of data on these pregnancies, their
management and outcomes are needed.
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